Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China · Delayed Price · Currency is CNY 62.77
+0.97 (1.57%)
Apr 29, 2026, 4:00 PM EDT
Hangzhou AGS MedTech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 221.98 | 221.44 | 293.39 | 217.24 | 144.96 | 104.8 |
Depreciation & Amortization | 13.56 | 13.56 | 8.85 | 6.56 | 6.26 | 4.4 |
Other Amortization | 2.58 | 2.58 | 1.2 | 1.14 | 1.44 | 1.96 |
Loss (Gain) From Sale of Assets | 0.05 | 0.05 | 0.19 | 0.35 | 0.14 | 0.01 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.02 | 0.46 | 1.96 | 1.01 |
Loss (Gain) From Sale of Investments | -36.97 | -36.97 | -21.63 | -2.11 | 7.19 | -1.72 |
Provision & Write-off of Bad Debts | - | - | -0.5 | 2.15 | - | - |
Other Operating Activities | 56.49 | 6.4 | 1.46 | 1.81 | -11.53 | 4.73 |
Change in Accounts Receivable | 10.08 | 10.08 | 9.42 | -39.77 | -8.19 | 0.08 |
Change in Inventory | -9.17 | -9.17 | -13.61 | -12.67 | -1.28 | -22.19 |
Change in Accounts Payable | -54.44 | -54.44 | 32.44 | 45.44 | 15.7 | 25.06 |
Change in Other Net Operating Assets | -1.43 | -1.43 | 3.91 | 2.4 | - | - |
Operating Cash Flow | 201.84 | 151.2 | 315.8 | 221.45 | 156.38 | 118.25 |
Operating Cash Flow Growth | -34.69% | -52.12% | 42.60% | 41.61% | 32.24% | 121.61% |
Capital Expenditures | -69.33 | -63.47 | -49.6 | -51.57 | -60.12 | -15.66 |
Sale of Property, Plant & Equipment | 0.5 | 0.5 | 0.04 | 0.08 | 0.03 | 0 |
Investment in Securities | - | - | -1,081 | -25.3 | -55 | - |
Other Investing Activities | 240.86 | -22.63 | - | - | -3.51 | 0.37 |
Investing Cash Flow | 172.02 | -85.6 | -1,130 | -76.79 | -118.6 | -15.29 |
Long-Term Debt Issued | - | 35 | - | - | - | - |
Long-Term Debt Repaid | - | - | -0.85 | -1.18 | -1.52 | -0.67 |
Total Debt Repaid | -35 | - | -0.85 | -1.18 | -1.52 | -0.67 |
Net Debt Issued (Repaid) | 30 | 35 | -0.85 | -1.18 | -1.52 | -0.67 |
Issuance of Common Stock | 6.82 | 6.82 | 5.87 | 1,820 | - | - |
Repurchase of Common Stock | - | - | -30.97 | - | - | - |
Common Dividends Paid | -111.21 | -111.2 | -83.33 | -43.98 | -35.95 | -49.05 |
Other Financing Activities | 12.51 | 12.95 | - | -177.6 | -1.15 | - |
Financing Cash Flow | -61.88 | -56.43 | -109.28 | 1,598 | -38.62 | -49.72 |
Foreign Exchange Rate Adjustments | -9.86 | -4.49 | 0.32 | 0.65 | 9.45 | -4.75 |
Net Cash Flow | 302.12 | 4.68 | -923.51 | 1,743 | 8.62 | 48.5 |
Free Cash Flow | 132.51 | 87.74 | 266.19 | 169.88 | 96.26 | 102.59 |
Free Cash Flow Growth | -50.54% | -67.04% | 56.70% | 76.48% | -6.17% | 308.62% |
Free Cash Flow Margin | 21.88% | 14.78% | 41.81% | 33.39% | 25.94% | 33.59% |
Free Cash Flow Per Share | 1.65 | 1.09 | 3.30 | 2.34 | 1.58 | 1.69 |
Cash Income Tax Paid | 63.81 | 72.8 | 72.45 | 42.18 | 19.73 | 17.57 |
Levered Free Cash Flow | 143.8 | -147.09 | 159.65 | 79.69 | 56.73 | 68.87 |
Unlevered Free Cash Flow | 143.8 | -147.09 | 159.65 | 79.69 | 56.73 | 68.87 |
Change in Working Capital | -55.86 | -55.86 | 32.83 | -6.15 | 5.96 | 3.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.